GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Dingdang Health Technology Group Ltd (HKSE:09886) » Definitions » ROE %

Dingdang Health Technology Group (HKSE:09886) ROE % : -10.89% (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Dingdang Health Technology Group ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Dingdang Health Technology Group's annualized net income for the quarter that ended in Dec. 2023 was HK$-248 Mil. Dingdang Health Technology Group's average Total Stockholders Equity over the quarter that ended in Dec. 2023 was HK$2,275 Mil. Therefore, Dingdang Health Technology Group's annualized ROE % for the quarter that ended in Dec. 2023 was -10.89%.

The historical rank and industry rank for Dingdang Health Technology Group's ROE % or its related term are showing as below:

HKSE:09886' s ROE % Range Over the Past 10 Years
Min: -10.6   Med: -10.58   Max: -10.58
Current: -10.6

During the past 6 years, Dingdang Health Technology Group's highest ROE % was -10.58%. The lowest was -10.60%. And the median was -10.58%.

HKSE:09886's ROE % is ranked worse than
73.28% of 610 companies
in the Healthcare Providers & Services industry
Industry Median: 4.32 vs HKSE:09886: -10.60

Dingdang Health Technology Group ROE % Historical Data

The historical data trend for Dingdang Health Technology Group's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dingdang Health Technology Group ROE % Chart

Dingdang Health Technology Group Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE %
Get a 7-Day Free Trial - - - - -10.58

Dingdang Health Technology Group Semi-Annual Data
Dec18 Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
ROE % Get a 7-Day Free Trial Premium Member Only - - - -10.34 -10.89

Competitive Comparison of Dingdang Health Technology Group's ROE %

For the Health Information Services subindustry, Dingdang Health Technology Group's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dingdang Health Technology Group's ROE % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Dingdang Health Technology Group's ROE % distribution charts can be found below:

* The bar in red indicates where Dingdang Health Technology Group's ROE % falls into.



Dingdang Health Technology Group ROE % Calculation

Dingdang Health Technology Group's annualized ROE % for the fiscal year that ended in Dec. 2023 is calculated as

ROE %=Net Income (A: Dec. 2023 )/( (Total Stockholders Equity (A: Dec. 2022 )+Total Stockholders Equity (A: Dec. 2023 ))/ count )
=-246.985/( (2440.756+2228.489)/ 2 )
=-246.985/2334.6225
=-10.58 %

Dingdang Health Technology Group's annualized ROE % for the quarter that ended in Dec. 2023 is calculated as

ROE %=Net Income (Q: Dec. 2023 )/( (Total Stockholders Equity (Q: Jun. 2023 )+Total Stockholders Equity (Q: Dec. 2023 ))/ count )
=-247.708/( (2320.604+2228.489)/ 2 )
=-247.708/2274.5465
=-10.89 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is two times the semi-annual (Dec. 2023) net income data. ROE % is displayed in the 30-year financial page.


Dingdang Health Technology Group  (HKSE:09886) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=-247.708/2274.5465
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-247.708 / 5708.484)*(5708.484 / 3446.3735)*(3446.3735 / 2274.5465)
=Net Margin %*Asset Turnover*Equity Multiplier
=-4.34 %*1.6564*1.5152
=ROA %*Equity Multiplier
=-7.19 %*1.5152
=-10.89 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=-247.708/2274.5465
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-247.708 / -235.37) * (-235.37 / -265.082) * (-265.082 / 5708.484) * (5708.484 / 3446.3735) * (3446.3735 / 2274.5465)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 1.0524 * 0.8879 * -4.64 % * 1.6564 * 1.5152
=-10.89 %

Note: The net income data used here is two times the semi-annual (Dec. 2023) net income data. The Revenue data used here is two times the semi-annual (Dec. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Dingdang Health Technology Group ROE % Related Terms

Thank you for viewing the detailed overview of Dingdang Health Technology Group's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Dingdang Health Technology Group (HKSE:09886) Business Description

Traded in Other Exchanges
N/A
Address
Dengshikou Street, Building 1, Yard 50, Dongcheng District, Beijing, CHN
Dingdang Health Technology Group Ltd is an investment holding company and its subsidiaries are principally engaged in the provision of pharmaceutical and healthcare business in the PRC. It is transforming and reshaping China's healthcare industry by pioneering on-demand pharmaceutical retail and medical consultation, with online-to-offline solutions.
Executives
Yang Yibin 2201 Interest of corporation controlled by you
Tpg Operating Group Iii, L.p. 2201 Interest of corporation controlled by you
Tpg Inc. 2201 Interest of corporation controlled by you
Zhao Yin Guo Ji Jin Rong Kong Gu Shen Zhen You Xian Gong Si 2201 Interest of corporation controlled by you
Zhao Yin Guo Ji Zi Ben Guan Li Shen Zhen You Xian Gong Si 2201 Interest of corporation controlled by you
Zhao Yin Guo Ji Jin Rong Kong Gu You Xian Gong Si 2201 Interest of corporation controlled by you
Zhao Yin Guo Ji Jin Rong You Xian Gong Si 2201 Interest of corporation controlled by you
Zhao Yin Jin Rong Kong Gu Shen Zhen You Xian Gong Si 2201 Interest of corporation controlled by you
Xing Xin You Xian Gong Si
Jian Xing You Xian Gong Si
Zhi Ying Ji Tuan You Xian Gong Si
Jian Fa You Xian Gong Si
Jin Fa You Xian Gong Si
Zhi Sheng Qi Ye You Xian Gong Si
Chuang Ji Tou Zi You Xian Gong Si

Dingdang Health Technology Group (HKSE:09886) Headlines

No Headlines